Company news

Shattuck Labs, Inc. news in 2021

Shattuck Labs, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Shattuck Labs Announces Preliminary Clinical Data from Ongoing Phase 1 Clinical Trials of ARC Fusion Proteins SL-172154 and SL-279252

November 8, 2021

Shattuck Labs to Host Conference Call and Webcast Highlighting Data Presented at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 3, 2021

Shattuck Labs Announces Changes to its Board of Directors

October 27, 2021

Shattuck Labs Reports Second Quarter 2021 Financial Results and Upcoming Phase 1 Dose Escalation Data for SL-172154 and SL-279252

August 10, 2021

Shattuck Labs Announces Participation in the BTIG Biotechnology Conference

August 5, 2021

Shattuck Labs Appoints Abhinav A. Shukla as Chief Technical Officer

May 31, 2021

Shattuck Labs Announces Participation in Upcoming May Conferences

April 29, 2021

Shattuck Labs Announces Participation in Needham’s 20th Annual Healthcare Conference

April 5, 2021

Shattuck Labs Announces Promotion of Andrew R. Neill to Chief Financial Officer

March 15, 2021

Shattuck Labs Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights

March 14, 2021

Shattuck Labs Announces Participation in Citi’s 2021 Virtual Immuno-Oncology Day

February 11, 2021

Decks in 2021